{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:23:11Z","timestamp":1792794191498,"version":"4.5.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100005971","name":"German Heart Foundation","doi-asserted-by":"publisher","award":["S\/06\/23"],"award-info":[{"award-number":["S\/06\/23"]}],"id":[{"id":"10.13039\/501100005971","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AngioWave"},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CellProthera"},{"name":"Cereno Scientific"},{"name":"High Enroll"},{"name":"Level Ex"},{"DOI":"10.13039\/100025122","name":"McKinsey","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025122","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medscape Cardiology"},{"name":"NirvaMed"},{"name":"PhaseBio"},{"name":"PLx Pharma","id":[{"id":"https:\/\/ror.org\/00d2efr72","id-type":"ROR","asserted-by":"crossref"}]},{"name":"American Heart Association New York City","id":[{"id":"https:\/\/ror.org\/013kjyp64","id-type":"ROR","asserted-by":"crossref"}]},{"name":"AngioWave"},{"name":"Broadview Ventures"},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hims"},{"name":"SFJ"},{"name":"Youngene;"},{"name":"Acesion Pharma","id":[{"id":"https:\/\/ror.org\/05b3amq72","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Assistance Publique-H\u00f4pitaux de Paris"},{"name":"Baim Institute for Clinical Research","id":[{"id":"https:\/\/ror.org\/01va8fr66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Harvard Clinical Research Institute","id":[{"id":"https:\/\/ror.org\/01va8fr66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"PORTICO"},{"name":"PEITHO"},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Contego Medical","id":[{"id":"https:\/\/ror.org\/0210ykj47","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Mount Sinai School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ENVISAGE"},{"name":"ABILITY-DM"},{"name":"ALLAY-HF"},{"name":"Alleviant Medical"},{"DOI":"10.13039\/100011132","name":"Rutgers University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012264","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012264","id-type":"DOI","asserted-by":"publisher"}]},{"name":"MINT"},{"DOI":"10.13039\/100005485","name":"American College of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Trials and News"},{"name":"ACC Accreditation Oversight Committee"},{"DOI":"10.13039\/100019944","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019944","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Bristol-Myers Squibb clopidogrel litigation"},{"name":"Baim Institute for Clinical Research","id":[{"id":"https:\/\/ror.org\/01va8fr66","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100013843","name":"Harvard Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013843","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01va8fr66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"RE-DUAL PCI"},{"name":"Boehringer Ingelheim; AEGIS-II","id":[{"id":"https:\/\/ror.org\/04fh1gw55","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100019361","name":"Belvoir Publications","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019361","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Harvard Heart Letter"},{"DOI":"10.13039\/501100024722","name":"Canadian Medical and Surgical Knowledge Translation Research Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014255","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014255","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AHA lecture"},{"name":"Cowen and Company"},{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PRONOUNCE"},{"name":"HMP Global"},{"name":"Journal of Invasive Cardiology"},{"name":"Journal of the American College of Cardiology","id":[{"id":"https:\/\/ror.org\/03pgm1r86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"K2P"},{"name":"Level Ex"},{"name":"Medtelligence"},{"name":"ReachMD"},{"name":"MJH Life Sciences"},{"name":"Oakstone CME"},{"name":"Comprehensive Review of Interventional Cardiology"},{"name":"Piper Sandler"},{"DOI":"10.13039\/100030936","name":"Population Health Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030936","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COMPASS"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"WebMD"},{"DOI":"10.13039\/100005134","name":"Wiley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005134","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Cardiology"},{"name":"Sotagliflozin"},{"DOI":"10.13039\/100005292","name":"Brigham and Women\u2019s Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000046","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000046","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Acesion Pharma","id":[{"id":"https:\/\/ror.org\/05b3amq72","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Afimmune"},{"name":"Aker BioMarine"},{"DOI":"10.13039\/100006400","name":"Alnylam","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014384","name":"Amarin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beren"},{"DOI":"10.13039\/100016242","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016242","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cardax","id":[{"id":"https:\/\/ror.org\/01xy18563","id-type":"ROR","asserted-by":"crossref"}]},{"name":"CellProthera"},{"name":"Cereno Scientific"},{"name":"CinCor"},{"name":"Cleerly"},{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009933","name":"Ethicon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009933","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faraday Pharmaceuticals"},{"DOI":"10.13039\/501100004914","name":"Ferring Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004914","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005632","name":"Forest Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005632","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fractyl","id":[{"id":"https:\/\/ror.org\/00byb9q66","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Garmin","id":[{"id":"https:\/\/ror.org\/0270n9q14","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018679","name":"HLS Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010721","name":"Ironwood","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010721","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ischemix"},{"DOI":"10.13039\/100005565","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003490","name":"Javelin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003490","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lexicon"},{"DOI":"10.13039\/100004312","name":"Lilly","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016619","name":"MyoKardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NirvaMed"},{"DOI":"10.13039\/100008272","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019120","name":"Otsuka","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019120","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Owkin"},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"PhaseBio"},{"name":"PLx Pharma","id":[{"id":"https:\/\/ror.org\/00d2efr72","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Recardio"},{"DOI":"10.13039\/100009857","name":"Regeneron","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Reid Hoffman Foundation"},{"DOI":"10.13039\/100014805","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021515","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021515","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Stasys"},{"name":"Synaptic"},{"DOI":"10.13039\/100015237","name":"The Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Youngene"},{"DOI":"10.13039\/100020887","name":"89Bio","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020887","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005201","name":"Elsevier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005201","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011952","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020576","name":"CSI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020576","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Endotronix","id":[{"id":"https:\/\/ror.org\/01h39y763","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004320","name":"Philips","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004320","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032137","name":"SpectraWAVE","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032137","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Svelte"},{"name":"Vascular Solutions"},{"DOI":"10.13039\/100015501","name":"American College of Cardiology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015501","id-type":"DOI","asserted-by":"publisher"}]},{"name":"FlowCo"},{"DOI":"10.13039\/100011948","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011948","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Affluent Medical"},{"name":"Alleviant Medical"},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"name":"BAIM"},{"DOI":"10.13039\/100005615","name":"Beth Israel Deaconess Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008021","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008021","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CardiaWave"},{"DOI":"10.13039\/100019719","name":"Chiesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019719","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030895","name":"Concept Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030895","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006510","name":"Duke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006510","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005962","name":"Faraday","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005962","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100016198","name":"Idorsia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100016198","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015324","name":"Janssen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023518","name":"MedAlliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023518","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medscape","id":[{"id":"https:\/\/ror.org\/05xyx5995","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Mediasphere"},{"name":"Medtelligence"},{"DOI":"10.13039\/501100011746","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011746","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Pi-Cardia"},{"name":"Protembis"},{"name":"RM Global Bioaccess Fund Management"},{"DOI":"10.13039\/100011421","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011421","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Affluent Medical"},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020218","name":"Chiesi USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006479","name":"Cordis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006479","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Esperion Science"},{"name":"Innovative BioPharma"},{"name":"IQVIA","id":[{"id":"https:\/\/ror.org\/01mk44223","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Medscape","id":[{"id":"https:\/\/ror.org\/05xyx5995","id-type":"ROR","asserted-by":"crossref"}]},{"name":"WebMD Global"},{"name":"PeerView Institute for Medical Education"},{"DOI":"10.13039\/100006274","name":"Radcliffe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006274","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Elixir Medical","id":[{"id":"https:\/\/ror.org\/05hgx8v86","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Stel"},{"name":"ControlRad"},{"DOI":"10.13039\/100032803","name":"SCAI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032803","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faculty Cardiovascular Research Foundation","id":[{"id":"https:\/\/ror.org\/04yxwc698","id-type":"ROR","asserted-by":"crossref"}]},{"name":"JAMA Cardiology"},{"DOI":"10.13039\/501100023296","name":"ACC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023296","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Inflammation contributes significantly to coronary artery disease (CAD). The neutrophil-to-lymphocyte ratio (NLR) has emerged as a readily available biomarker reflecting both inflammatory and immune cells\u2019 activity, potentially enhancing risk stratification of patients with CAD. This study evaluates the clinical impact of baseline NLR in patients undergoing percutaneous coronary intervention (PCI) for both chronic coronary syndrome and acute coronary syndrome (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of patients undergoing PCI at Mount Sinai Hospital between 2012 and 2022. Patients were stratified into NLR quartiles and outcomes were analysed using Cox regression models. The primary endpoint was major adverse cardiovascular events (MACEs) at 1-year follow-up, including all-cause death, myocardial infarction (MI), and stroke. A total of 7287 patients were included in the study. Age, male sex, comorbidities, high-sensitivity C-reactive protein, and complexity of PCI tended to be higher in the highest NLR quartiles. At 1 year, MACE incidence increased across NLR quartiles, from 5.1% (1st quartile) to 9.3% (4th quartile) (P for trend = 0.004). Compared with the 1st quartile, the 4th NLR quartile (NLR &amp;gt; 5.0) was associated with increased adjusted risks of MACE [adjusted hazard ratio (adjHR) 1.52, 95% CI 1.12\u20132.05], all-cause death (adjHR 1.71, 95% CI 1.10\u20132.65), MI (adjHR 1.53, 95% CI 1.00\u20132.35), and bleeding (adjHR 2.01, 95% CI 1.50\u20132.70). Ischaemic risk associated with high NLR was more pronounced in patients presenting with ACS and chronic kidney disease (CKD).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Baseline NLR is associated with adverse cardiovascular outcomes in CAD patients undergoing PCI. Assessment of NLR could enhance risk stratification particularly in patients with ACS and CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwaf597","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:24:19Z","timestamp":1759310659000},"page":"669-678","source":"Crossref","is-referenced-by-count":9,"title":["Association of neutrophil-to-lymphocyte ratio with clinical outcomes after percutaneous coronary intervention"],"prefix":"10.1093","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0561-7563","authenticated-orcid":false,"given":"Angelo","family":"Oliva","sequence":"first","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]},{"name":"Department of Biomedical Sciences, Humanitas University , via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Pieve Emanuele (MI), Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9896-403X","authenticated-orcid":false,"given":"Birgit","family":"Vogel","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0618-9409","authenticated-orcid":false,"given":"Samantha","family":"Sartori","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7755-4069","authenticated-orcid":false,"given":"Davide","family":"Cao","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]},{"name":"Department of Biomedical Sciences, Humanitas University , via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Pieve Emanuele (MI), Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth F","family":"Smith","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Bay","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]},{"name":"Department of Cardiology, University Heart & Vascular Center Hamburg, University Medical Center Hamburg-Eppendorf , Hamburg ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Sweeny","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M","family":"Di Muro","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]},{"name":"Department of Experimental and Clinical Medicine, School of Human Health Sciences, Careggi University Hospital, University of Florence \u00a0 Florence 50134 ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Danias","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Sciences, Northeastern University , Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Moreno","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Gitto","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]},{"name":"Department of Biomedical Sciences, Humanitas University , via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Pieve Emanuele (MI), Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio G","family":"Stefanini","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University , via Rita Levi Montalcini 4, 20072 Pieve Emanuele, Pieve Emanuele (MI), Milan ,","place":["Italy"]},{"name":"Cardio Center, IRCCS Humanitas Research Hospital , Rozzano, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J","family":"Pocock","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, London School of Hygiene and Tropical Medicine , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1278-6245","authenticated-orcid":false,"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Dangas","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Ridker","sequence":"additional","affiliation":[{"name":"Divisions of Preventive Medicine and Cardiovascular Diseases, Brigham and Women\u2019s Hospital, Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annapoorna S","family":"Kini","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samin K","family":"Sharma","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[{"name":"Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai , One Gustave L. Levy Place, Box 1030, New York, NY 10029 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026032619563582600_zwaf597-B1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"2026032619563582600_zwaf597-B2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/eurheartj\/ehad486","article-title":"Inflammation in acute myocardial infarction: the good, the bad and the ugly","volume":"45","author":"Matter","year":"2023","journal-title":"Eur Heart J"},{"key":"2026032619563582600_zwaf597-B3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(23)00215-5","article-title":"Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials","volume":"401","author":"Ridker","year":"2023","journal-title":"Lancet"},{"key":"2026032619563582600_zwaf597-B4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00392-024-02471-w","article-title":"Inflammatory risk and clinical outcomes according to polyvascular atherosclerotic disease status in patients undergoing PCI","volume":"114","author":"Bay","year":"2025","journal-title":"Clin Res Cardiol"},{"key":"2026032619563582600_zwaf597-B5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"key":"2026032619563582600_zwaf597-B6","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/eurheartj\/ehaa1034","article-title":"The neutrophil\u2013lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trials","volume":"42","author":"Adamstein","year":"2021","journal-title":"Eur Heart J"},{"key":"2026032619563582600_zwaf597-B7","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.jacc.2015.11.037","article-title":"A test in context: high-sensitivity C-reactive protein","volume":"67","author":"Ridker","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026032619563582600_zwaf597-B8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/MCA.0000000000001040","article-title":"The prognostic value of neutrophil-to-lymphocyte ratio across all stages of coronary artery disease","volume":"33","author":"Agarwal","year":"2022","journal-title":"Coron Artery Dis"},{"key":"2026032619563582600_zwaf597-B9","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/heartjnl-2024-325396","article-title":"Prognostic impact of neutrophil-to-lymphocyte ratio in patients with and without diabetes mellitus undergoing percutaneous coronary intervention","volume":"111","author":"Di Muro","year":"2025","journal-title":"Heart"},{"key":"2026032619563582600_zwaf597-B10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(17)32814-3","article-title":"Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial","volume":"391","author":"Ridker","year":"2018","journal-title":"The Lancet"},{"key":"2026032619563582600_zwaf597-B11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1001\/jamacardio.2022.4277","article-title":"Association of interleukin 6 inhibition with ziltivekimab and the neutrophil-lymphocyte ratio: a secondary analysis of the RESCUE clinical trial","volume":"8","author":"Adamstein","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026032619563582600_zwaf597-B12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/eurheartj\/ehaa099","article-title":"Targeting cardiovascular inflammation: next steps in clinical translation","volume":"42","author":"Lawler","year":"2020","journal-title":"Eur Heart J"},{"key":"2026032619563582600_zwaf597-B13","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1093\/eurheartj\/ehy310","article-title":"Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the canakinumab anti-inflammatory thrombosis outcomes study (CANTOS)","volume":"39","author":"Ridker","year":"2018","journal-title":"Eur Heart J"},{"key":"2026032619563582600_zwaf597-B14","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026032619563582600_zwaf597-B15","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ Res"},{"key":"2026032619563582600_zwaf597-B16","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1016\/j.jacc.2005.02.054","article-title":"Which white blood cell subtypes predict increased cardiovascular risk?","volume":"45","author":"Horne","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2026032619563582600_zwaf597-B17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1126\/science.1230719","article-title":"Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure","volume":"339","author":"Swirski","year":"2013","journal-title":"Science"},{"key":"2026032619563582600_zwaf597-B18","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12933-022-01583-9","article-title":"High neutrophil to lymphocyte ratio with type 2 diabetes mellitus predicts poor prognosis in patients undergoing percutaneous coronary intervention: a large-scale cohort study","volume":"21","author":"He","year":"2022","journal-title":"Cardiovasc Diabetol"},{"key":"2026032619563582600_zwaf597-B19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.atherosclerosis.2009.01.029","article-title":"Relationship between low lymphocyte count and major cardiac events in patients with acute chest pain, a non-diagnostic electrocardiogram and normal troponin levels","volume":"206","author":"N\u00fa\u00f1ez","year":"2009","journal-title":"Atherosclerosis"},{"key":"2026032619563582600_zwaf597-B20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1586\/erc.12.159","article-title":"Neutrophil to lymphocyte ratio and cardiovascular diseases: a review","volume":"11","author":"Bhat","year":"2013","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"2026032619563582600_zwaf597-B21","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/eurheartj\/ehaa1104","article-title":"Immune cell-based cardiovascular risk assessment: spotlight on the neutrophil-lymphocyte ratio","volume":"42","author":"Sager","year":"2021","journal-title":"Eur Heart J"},{"key":"2026032619563582600_zwaf597-B22","doi-asserted-by":"crossref","first-page":"4832","DOI":"10.1093\/eurheartj\/ehac444","article-title":"Inflammation drives residual risk in chronic kidney disease: a CANTOS substudy","volume":"43","author":"Ridker","year":"2022","journal-title":"Eur Heart J"},{"key":"2026032619563582600_zwaf597-B23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.jacc.2021.02.049","article-title":"Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction","volume":"77","author":"Broch","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026032619563582600_zwaf597-B24","doi-asserted-by":"crossref","first-page":"104013","DOI":"10.1016\/j.ebiom.2022.104013","article-title":"Interleukin-6 inhibition in ST-elevation myocardial infarction: immune cell profile in the randomised ASSAIL-MI trial","volume":"80","author":"Huse","year":"2022","journal-title":"EBioMedicine"},{"key":"2026032619563582600_zwaf597-B25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41598-022-05374-w","article-title":"Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction","volume":"12","author":"Del Buono","year":"2022","journal-title":"Sci Rep"},{"key":"2026032619563582600_zwaf597-B26","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s12265-018-9829-6","article-title":"Impact of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio on 5-year clinical outcomes of patients with stable coronary artery disease undergoing elective percutaneous coronary intervention","volume":"11","author":"Bressi","year":"2018","journal-title":"J Cardiovasc Transl Res"},{"key":"2026032619563582600_zwaf597-B27","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.atherosclerosis.2017.08.007","article-title":"Pre-procedural neutrophil-to-lymphocyte ratio and long-term cardiac outcomes after percutaneous coronary intervention for stable coronary artery disease","volume":"265","author":"Wada","year":"2017","journal-title":"Atherosclerosis"},{"key":"2026032619563582600_zwaf597-B28","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cca.2008.04.019","article-title":"Predictive value of elevated neutrophil\u2013lymphocyte ratio on cardiac mortality in patients with stable coronary artery disease","volume":"395","author":"Papa","year":"2008","journal-title":"Clin Chim Acta"},{"key":"2026032619563582600_zwaf597-B29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ahj.2022.10.001","article-title":"Race and outcomes after percutaneous coronary intervention: insights from the blue cross blue shield of Michigan cardiovascular consortium","volume":"255","author":"Spehar","year":"2023","journal-title":"Am Heart J"},{"key":"2026032619563582600_zwaf597-B30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MCA.0000000000000237","article-title":"Racial differences in the neutrophil-to-lymphocyte ratio in patients with non-ST-segment elevation myocardial infarction","volume":"26","author":"Misumida","year":"2015","journal-title":"Coron Artery Dis"},{"key":"2026032619563582600_zwaf597-B31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.2011.178","article-title":"Novel inflammatory mechanisms of accelerated atherosclerosis in kidney disease","volume":"80","author":"Swaminathan","year":"2011","journal-title":"Kidney Int"},{"key":"2026032619563582600_zwaf597-B32","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1080\/0886022X.2020.1832521","article-title":"Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"42","author":"Zhao","year":"2020","journal-title":"Ren Fail"},{"key":"2026032619563582600_zwaf597-B33","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamacardio.2021.3079","article-title":"Interleukin 6 and cardiovascular outcomes in patients with chronic kidney disease and chronic coronary syndrome","volume":"6","author":"Batra","year":"2021","journal-title":"JAMA Cardiol"},{"key":"2026032619563582600_zwaf597-B34","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"The Lancet"},{"key":"2026032619563582600_zwaf597-B35","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijcard.2023.05.031","article-title":"Neutrophil-lymphocyte ratio and clinical outcomes in 19,697 patients with atrial fibrillation: analyses from ENGAGE AF- TIMI 48 trial","volume":"386","author":"Fagundes","year":"2023","journal-title":"Int J Cardiol"},{"key":"2026032619563582600_zwaf597-B36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4244\/EIJ-D-20-01197","article-title":"Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis","volume":"17","author":"Piccolo","year":"2021","journal-title":"EuroIntervention"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/advance-article-pdf\/doi\/10.1093\/eurjpc\/zwaf597\/64459284\/zwaf597.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/5\/669\/64459284\/zwaf597.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/33\/5\/669\/64459284\/zwaf597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:57:01Z","timestamp":1774569421000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/33\/5\/669\/8269756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":36,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,10,1]]},"published-print":{"date-parts":[[2026,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwaf597","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,3]]},"published":{"date-parts":[[2025,10,1]]}}}